Publications by authors named "Gabriele Buda"

Claim this Profile
L
Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients.
Gregorio Barilà, Angela Grassi, Concetta Conticello, Roberto Mina, Chiara Marcon, Gabriele Buda

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework.
Mario Boccadoro, Angelo Belotti, Felice Bombaci, Sara Bringhen, Gabriele Buda

BMC Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Light chain deposition disease: pathogenesis, clinical characteristics and treatment strategies.
Raffaella Cassano Cassano, Angelo Giovanni Bonadio, Maria Livia Del Giudice, Domenico Giannese, Sara Galimberti, Gabriele Buda

Ann Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, Sofia Terlizzi, Giovanni Reddiconto, Gabriele Buda

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions.
Yu Fu Ferrari Chen, Alberto Aimo, Vincenzo Castiglione, Olena Chubuchna, Paolo Morfino, Gabriele Buda

Curr Heart Fail Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis.
Giuseppe Vergaro, Alberto Aimo, Dario Genovesi, Lucas Soares Bezerra, Vincenzo Castiglione, Gabriele Buda

Eur Heart J Cardiovasc Imaging· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How First-Line Therapy is Changing in Transplant-Eligible Multiple Myeloma Patients.
Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Mediterr J Hematol Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of isatuximab-pomalidomide-dexamethasone elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.
Enrica Antonia Martino, Annalisa Pitino, Massimo Offidani, Roberta Della Pepa, Alessandro Gozzetti, Gabriele Buda

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Role of Soluble B-Cell Maturation Antigen in Short-Term Monitoring of Differently Treated Multiple Myeloma Patients: A Prospective Study.
Laura Caponi, Maria Livia Del Giudice, Alice Botti, Silvia Ursino, Alberto Gennari, Gabriele Buda

J Clin Lab Anal· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.
Sonia Morè, Irene Federici, Alessandra Bossi, Serena Rupoli, Erika Morsia, Gabriele Buda

Hemasphere· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Antibodies in Relapsed-Refractory Multiple Myeloma.
Ilaria Sorgiovanni, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Pharmaceuticals (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis.
Raffaella Cassano Cassano, Dario Genovesi, Giuseppe Vergaro, Assuero Giorgetti, Alberto Aimo, Gabriele Buda

Eur J Clin Invest· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy.
Vanda Strafella, Immacolata Attolico, Paola Carluccio, Francesco Tarantini, Paola Curci, Gabriele Buda

Ann Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.
Alberto Aimo, Giuseppe Vergaro, Vincenzo Castiglione, Iacopo Fabiani, Andrea Barison, Gabriele Buda

Eur J Prev Cardiol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis.
Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Hematol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management.
Serena Barachini, Gabriele Buda, Iacopo Petrini

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents.
Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Cancer Immunol Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.
Angelica Macauda, Klara Briem, Alyssa Clay-Gilmour, Wendy Cozen, Asta Försti, Gabriele Buda

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Esther Clavero, José Manuel Sanchez-Maldonado, Angelica Macauda, Rob Ter Horst, Belém Sampaio-Marques, Gabriele Buda

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
Elisabetta Antonioli, Sofia Pilerci, Irene Attucci, Gabriele Buda, Alessandro Gozzetti

Front Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis.
Giuseppe Vergaro, Vincenzo Castiglione, Alberto Aimo, Concetta Prontera, Silvia Masotti, Gabriele Buda

Eur J Heart Fail· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Marco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, Angelica Macauda, Juan Sainz, Gabriele Buda

Int J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib-related glomerular and tubular injury in a patient with Multiple Myeloma.
Domenico Giannese, Angelo Giovanni Bonadio, Maria Lavinia Del Giudice, Adamasco Cupisti, Gabriele Buda

J Nephrol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial amyloidosis: mechanisms and clinical manifestations.
Giuseppe Vergaro, Alberto Aimo, Claudio Rapezzi, Vincenzo Castiglione, Iacopo Fabiani, Gabriele Buda

Eur J Heart Fail· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro-prospective observational study.
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Irene Attucci, Ludovica Pengue, Gabriele Buda

Eur J Haematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis